KRAS mutation in colorectal cancer metastases after adjuvant FOLFOX for the primary

被引：0
|
作者：
J-N Vauthey
S Kopetz
T A Aloia
A Andreou
机构：
[1] The University of Texas MD Anderson Cancer Center,Department of Surgical Oncology
[2] The University of Texas MD Anderson Cancer Center,Department of Gastrointestinal Medical Oncology
来源：
British Journal of Cancer | 2012年 / 107卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1442 / 1443
页数：1
相关论文
共 50 条
  • [21] KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
    Y Kawamoto
    K Tsuchihara
    T Yoshino
    N Ogasawara
    M Kojima
    M Takahashi
    A Ochiai
    H Bando
    N Fuse
    M Tahara
    T Doi
    H Esumi
    Y Komatsu
    A Ohtsu
    British Journal of Cancer, 2012, 107 : 340 - 344
  • [22] KRAS mutations in primary tumours and post-FOLFOX metastatic lesions in cases of colorectal cancer
    Kawamoto, Y.
    Tsuchihara, K.
    Yoshino, T.
    Ogasawara, N.
    Kojima, M.
    Takahashi, M.
    Ochiai, A.
    Bando, H.
    Fuse, N.
    Tahara, M.
    Doi, T.
    Esumi, H.
    Komatsu, Y.
    Ohtsu, A.
    BRITISH JOURNAL OF CANCER, 2012, 107 (02) : 340 - 344
  • [23] KRAS Mutation Testing in Colorectal Cancer
    Plesec, Thomas P.
    Hunt, Jennifer L.
    ADVANCES IN ANATOMIC PATHOLOGY, 2009, 16 (04) : 196 - 203
  • [24] KRAS gene mutation in colorectal cancer
    Roa, Ivan
    Sanchez, Tamara
    Majlis, Alejandro
    Schalper, Kurt
    REVISTA MEDICA DE CHILE, 2013, 141 (09) : 1166 - 1172
  • [25] KRAS Mutation Status in Primary Nonsmall Cell Lung Cancer and Matched Metastases
    Cortot, Alexis B.
    Italiano, Antoine
    Burel-Vandenbos, Fanny
    Martel-Planche, Ghyslaine
    Hainaut, Pierre
    CANCER, 2010, 116 (11) : 2682 - 2687
  • [26] SYSTEMIC ADJUVANT CHEMOTHERAPY AFTER RESECTION OF COLORECTAL CANCER METASTASES
    Brandi, G.
    Derenzini, E.
    Pantaleo, M. A.
    Di Battista, M.
    Ravaioli, M.
    Ercolani, G.
    Grazi, G. L.
    Fanello, S.
    Di Marco, M.
    Nobili, E.
    Hakim, R.
    Poggi, R.
    Palmerini, E.
    Biasco, G.
    ANNALS OF ONCOLOGY, 2004, 15 : 66 - 66
  • [27] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Myung Hee Chang
    In Kyu Lee
    Yoon Si
    Kyu Sang Lee
    In-Sook Woo
    Jae Ho Byun
    Cancer Chemotherapy and Pharmacology, 2011, 68 : 317 - 323
  • [28] Clinical impact of K-ras mutation in colorectal cancer patients treated with adjuvant FOLFOX
    Chang, Myung Hee
    Lee, In Kyu
    Si, Yoon
    Lee, Kyu Sang
    Woo, In-Sook
    Byun, Jae Ho
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (02) : 317 - 323
  • [29] Heterogeneity of Kras status in primary colorectal cancer and corresponding liver metastases.
    Kaneko, Y.
    Kuramochi, H.
    Nakajima, G.
    Nakamura, A.
    Inoue, Y.
    Hayashi, K.
    Yamamoto, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [30] Intratumoral heterogeneity of KRAS and BRAF mutations in primary colorectal cancer and corresponding metastases
    Zlobec, I.
    Bihl, M.
    Foerster, A.
    Rufle, A.
    Lugli, A.
    VIRCHOWS ARCHIV, 2011, 459 : S318 - S318
12345